264 related articles for article (PubMed ID: 23573302)
1. Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures.
Aaberg-Jessen C; Nørregaard A; Christensen K; Pedersen CB; Andersen C; Kristensen BW
Int J Clin Exp Pathol; 2013; 6(4):546-60. PubMed ID: 23573302
[TBL] [Abstract][Full Text] [Related]
2. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
3. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
Li MW; Niu CS
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.
Jensen SS; Meyer M; Petterson SA; Halle B; Rosager AM; Aaberg-Jessen C; Thomassen M; Burton M; Kruse TA; Kristensen BW
PLoS One; 2016; 11(7):e0159746. PubMed ID: 27454178
[TBL] [Abstract][Full Text] [Related]
5. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
6. The pathological characteristics of glioma stem cell niches.
He H; Li MW; Niu CS
J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
[TBL] [Abstract][Full Text] [Related]
7. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.
Yi L; Zhou ZH; Ping YF; Chen JH; Yao XH; Feng H; Lu JY; Wang JM; Bian XW
Mod Pathol; 2007 Oct; 20(10):1061-8. PubMed ID: 17660801
[TBL] [Abstract][Full Text] [Related]
9. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium.
Christensen K; Aaberg-Jessen C; Andersen C; Goplen D; Bjerkvig R; Kristensen BW
Neurosurgery; 2010 May; 66(5):933-47. PubMed ID: 20404698
[TBL] [Abstract][Full Text] [Related]
11. An advanced glioma cell invasion assay based on organotypic brain slice cultures.
Eisemann T; Costa B; Strelau J; Mittelbronn M; Angel P; Peterziel H
BMC Cancer; 2018 Jan; 18(1):103. PubMed ID: 29378533
[TBL] [Abstract][Full Text] [Related]
12. What is the clinical value of cancer stem cell markers in gliomas?
Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
[TBL] [Abstract][Full Text] [Related]
13. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.
Wan Y; Fei XF; Wang ZM; Jiang DY; Chen HC; Yang J; Shi L; Huang Q
Chin J Cancer; 2012 Apr; 31(4):207-14. PubMed ID: 22360855
[TBL] [Abstract][Full Text] [Related]
14. Detection of cancer stem cells from the C6 glioma cell line.
Zhou XD; Wang XY; Qu FJ; Zhong YH; Lu XD; Zhao P; Wang DH; Huang QB; Zhang L; Li XG
J Int Med Res; 2009; 37(2):503-10. PubMed ID: 19383245
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
16. Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model.
Jung S; Kim HW; Lee JH; Kang SS; Rhu HH; Jeong YI; Yang SY; Chung HY; Bae CS; Choi C; Shin BA; Kim KK; Ahn KY
J Cancer Res Clin Oncol; 2002 Sep; 128(9):469-76. PubMed ID: 12242510
[TBL] [Abstract][Full Text] [Related]
17. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
[TBL] [Abstract][Full Text] [Related]
18. Study on the proliferation and drug-resistance of human brain tumor stem-like cells.
Qin K; Jiang X; Zou Y; Wang J; Qin L; Zeng Y
Cell Mol Neurobiol; 2010 Aug; 30(6):955-60. PubMed ID: 20526804
[TBL] [Abstract][Full Text] [Related]
19. Glioma spheroids obtained via ultrasonic aspiration are viable and express stem cell markers: a new tissue resource for glioma research.
Jensen SS; Aaberg-Jessen C; Andersen C; Schrøder HD; Kristensen BW
Neurosurgery; 2013 Nov; 73(5):868-86; discussion 886. PubMed ID: 23887192
[TBL] [Abstract][Full Text] [Related]
20. Stem cell markers in gliomas.
Dell'Albani P
Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
